Mitzi Barmatz, MD
Urology · Tucson, AZNPI 1700888039
Payments from drug & device makers
Across 371 payments — averaging $423.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$71K
- Caldera Medical, Inc$55K
- Bluewind Medical$23K
- Neotract Inc.$2K
- Teleflex LLC$1K
- Medtronic$923
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 113 | $71,305 |
| Caldera Medical, Inc | 71 | $55,394 |
| Bluewind Medical | 22 | $22,854 |
| Neotract Inc. | 14 | $1,690 |
| Teleflex LLC | 9 | $1,205 |
| Medtronic(2 entities) | 26 | $923 |
| AbbVie(2 entities) | 20 | $471 |
| Axonics, Inc. | 10 | $455 |
| Intuitive Surgical | 5 | $413 |
| Sumitomo Pharma America, Inc. | 12 | $310 |
| Boston Scientific | 8 | $287 |
| Astellas Pharma US Inc | 13 | $277 |
| Procept Biorobotics Corporation | 3 | $270 |
| Bayer | 8 | $213 |
| Johnson & Johnson | 2 | $151 |
| Valencia Technologies Corporation | 1 | $138 |
| Dendreon Pharmaceuticals LLC | 3 | $68 |
| Endo Pharmaceuticals Inc. | 4 | $62 |
| Pfizer | 4 | $61 |
| 180 Medical, Inc. | 3 | $60 |
| AstraZeneca | 2 | $50 |
| Tolmar Pharmaceuticals, Inc. | 2 | $41 |
| Myovant Sciences Inc. | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| Urogen Pharma, Inc. | 2 | $35 |
| Progenics Pharmaceuticals, Inc. | 1 | $28 |
| Tolmar, Inc. | 1 | $23 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $22 |
| Coopersurgical, Inc. | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $17 |
| Blue Earth Diagnostics | 1 | $17 |
| Urovant Sciences Inc | 1 | $16 |
| Amgen | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
How this compares
$157,000 in reported general payments places this provider in the 95th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Tucson
- Curtis DunsheeTucson$16M
- Kalpesh PatelTucson$2.3M
- Susan KalotaTucson$1.2M
- Kenneth BelkoffTucson$52K
- Benjamin LeeTucson$36K
- Thomas TieuTucson$25K
- Karen WheelerTucson$22K
- Juan ChipolliniTucson$19K
- Tristan BerryTucson$14K
- Mark TysonScottsdale$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.